Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of these ...
As we celebrate the third anniversary of Cancer Research Communications (CRC), we reflect on the remarkable journey we have undertaken since assuming the roles of co-Editors-in-Chief. Our mission from ...